» Articles » PMID: 14527409

Identification of Modulators of TRAIL-induced Apoptosis Via RNAi-based Phenotypic Screening

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2003 Oct 7
PMID 14527409
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

New opportunities in mammalian functional genomics are emerging through the combination of high throughput technology and methods that allow manipulation of gene expression in living cells. Here we describe the application of an RNAi-based forward genomics approach toward understanding the biology and mechanism of TRAIL-induced apoptosis. TRAIL is a TNF superfamily member that induces selective cytotoxicity of tumor cells when bound to its cognate receptors. In addition to detecting well-characterized genes in the apoptosis pathway, we uncover several modulators including DOBI, a gene required for progression of the apoptotic signal through the intrinsic mitochondrial cell death pathway, and MIRSA, a gene that acts to limit TRAIL-induced apoptosis. Moreover, our data suggest a role for MYC and the WNT pathway in maintaining susceptibility to TRAIL. Collectively, these observations offer several insights on how TRAIL mediates the selective killing of tumor cells and demonstrate the utility of large-scale RNAi screens in mammalian cells.

Citing Articles

MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists.

Espinosa-Gil S, Ivanova S, Alari-Pahissa E, Denizli M, Villafranca-Magdalena B, Vinas-Casas M Cell Death Dis. 2023; 14(11):715.

PMID: 37919293 PMC: 10622508. DOI: 10.1038/s41419-023-06229-6.


Target identification of small molecules: an overview of the current applications in drug discovery.

Tabana Y, Babu D, Fahlman R, Siraki A, Barakat K BMC Biotechnol. 2023; 23(1):44.

PMID: 37817108 PMC: 10566111. DOI: 10.1186/s12896-023-00815-4.


HIF1A-repressed PUS10 regulates NUDC/Cofilin1 dependent renal cell carcinoma migration by promoting the maturation of miR-194-5p.

Luo W, Xu Z, Wang H, Lu Z, Ding L, Wang R Cell Biosci. 2023; 13(1):153.

PMID: 37596681 PMC: 10439626. DOI: 10.1186/s13578-023-01094-4.


Biochemistry-informed design selects potent siRNAs against SARS-CoV-2.

Houbron E, Mockly S, Rafasse S, Gros N, Muriaux D, Seitz H RNA Biol. 2023; 20(1):272-280.

PMID: 37272117 PMC: 10243379. DOI: 10.1080/15476286.2023.2217400.


Small interfering RNA for cancer treatment: overcoming hurdles in delivery.

Charbe N, Amnerkar N, Ramesh B, Tambuwala M, Bakshi H, Aljabali A Acta Pharm Sin B. 2020; 10(11):2075-2109.

PMID: 33304780 PMC: 7714980. DOI: 10.1016/j.apsb.2020.10.005.